Financials

  • Market Capitalization 84.19 M
  • Employee 9
  • Founded 2018
  • CEO N/A
  • Website www.rallybio.com
  • Headquarter Delaware, United States
  • FIGI BBG011PFKF54
  • Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.45
Price to sales ratio
36.01

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
4055
NRXS
Neuraxis, Inc. Common Stock
6.88 USD-3.64%-7.28%-1.15%+26.70%85.20 M USD
4057
ACRV
Acrivon Therapeutics, Inc. - Common Stock
1.98 USD+1.02%+9.39%+27.74%+48.87%84.75 M USD
4086
ENTX
Entera Bio Ltd. - Ordinary Shares
1.64 USD-1.20%-4.65%+31.20%-7.34%80.73 M USD
4087
CSBR
Champions Oncology, Inc. - Common Stock
5.81 USD-0.17%+1.40%-10.48%-27.83%80.68 M USD

Frequently asked questions about Rallybio Corporation - Common Stock

What is the Rallybio Corporation - Common Stock stock price today?

The current price of Rallybio Corporation - Common Stock (RLYB) is 15.89. Over the past 24 hours, the stock has changed by +1.02%. Follow the RLYB chart for real-time price dynamics.

What is the stock ticker of Rallybio Corporation - Common Stock?

Rallybio Corporation - Common Stock trades under the ticker RLYB. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Rallybio Corporation - Common Stock stock going up?

RLYB has changed by +0.19% over the last week, -0.50% over the last month, and +3431.11% over the last year. Review the chart to see whether the current move is part of a broader trend.

What was Rallybio Corporation - Common Stock net income for the last quarter?

Rallybio Corporation - Common Stock reported net income of -8.28 M for the last quarter. The previous quarter showed -5.85 M, which means net income changed by -41.46%.

How many employees does Rallybio Corporation - Common Stock have?

As of the latest available data, Rallybio Corporation - Common Stock has 9 employees. Workforce size can provide additional context about the company's scale and operations.

What is Rallybio Corporation - Common Stock EBITDA?

Rallybio Corporation - Common Stock EBITDA is -8.78 M, and its EBITDA margin is -4 143.4%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Rallybio Corporation - Common Stock stock?

You can buy Rallybio Corporation - Common Stock (RLYB) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Rallybio Corporation - Common Stock stock?

Investing in Rallybio Corporation - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RLYB chart and related analysis on metatrader.com as part of your research.

News